Eskitis Institute for Cell and Molecular Therapies
The Eskitis Institute for Cell and Molecular Therapies investigates novel drug- and cell-based therapies for human diseases in the thematic areas of:
- Cancer
- Infection and immunity
- Neglected diseases
- Neurodegenerative diseases
- Stem cell biology
The Institute works towards the development of new strategies to prevent and treat disease with an emphasis on multi-disciplinary research and collaboration within the Institute and with national and international partners
Eskitis has attracted exceptional expertise and established cutting edge facilities.
Collaborating Partners
- Pfizer - Press release: New partnership to unlock nature's cure for infections
- AstraZeneca - Press Release: Promising leads pursued in Griffith University, AstraZeneca collaboration
- Innate Pharmaceuticals - Press Release: Experts hunt bacteria blockers
- Medicines for Malaria Venture - Press Release: Unique malaria project scoops international award
- Drugs for Neglected Diseases Initiative
Eskitis incorporates
Investigating the biology of adult stem cells in cell transplantation therapies, disease biology and drug discovery
Australia's only dedicated compound management and logistics facility
Node of the Cancer Therapeutics CRC - bridging the gap between cutting edge cancer biology and new drugs for the treatment of cancer
Partners
